Skip to content

An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)

An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine) and the Changes of Symptoms According to the Treatment Effect of Hypertension for Korean Hypertensive Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06214832
Enrollment
4000
Registered
2024-01-22
Start date
2021-11-11
Completion date
2025-08-30
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

This study identify prescription patterns of Lodient Tab and evaluate the changes of the hypertension symptoms (BP pressure) who are first prescribed and taking Lodient Tab.

Detailed description

This study aims to observe changes in symptoms according to the treatment effect of hypertension for 6 months after Lodient Tab prescription.

Interventions

None listed

Sponsors

Hanlim Pharm. Co., Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adults over 19 years of age 2. A person diagnosed with hypertension 3. A person who has been first prescribed Lodient Tab within the past 4 months as of the IRB approval date or is scheduled to be prescribed Lodient Tab 4. A person who voluntarily agreed in writing to this study

Exclusion criteria

1. Pregnant women or nursing mothers 2. Persons subject to prohibition according to the permission of the Lodient Tab 3. Patients who in the judgement of the investigator, were inappropriate to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
The percentage of patients who met target systolic blood pressure (less than 140mmHg) at 6 months of prescription for Lodient Tab compared to baselineat 6 months of prescription for Lodient Tab compared to baselineThe percentage of patients who met target systolic blood pressure (less than 140mmHg) at 6 months of prescription for Lodient Tab compared to baseline

Countries

South Korea

Contacts

Primary ContactMinseob Song
song2you@naver.com+820222737282

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026